The Study of Resibufogenin on Induction of the Apoptosis of Human Hepatocarcinoma Bel-7402 Cells by the Mitochondrial-dependent Pathway

黄应申,肖军军,孟书聪,董晓敏,王传社,果德安
DOI: https://doi.org/10.3969/j.issn.1000-8179.2006.20.001
2006-01-01
Chinese Journal of Clinical Oncology
Abstract:Objective: To detect the effects of resibufogenin (RG), a main constituent of Chinese drug Chan Su, on human hepatoma carcinoma Bel-7402 cell line and initial approach the mechanism of its effect. Methods: Bel-7402 was cultured in vitro and then acid phosphatase assay (APA) was used to evaluate the anti-proliferation effect of RG, morphological change was observed by acridine orange (AO) staining, FCM was applied to analyse the apoptotic rate and detect changes in mitochondrial transmembrane potential (Δψm), and the expression of apoptosis-related proteins were determined by western blot. Results: Resibufogenin significantly inhibited the proliferation of Bel-7402 cells, the 50% inhibitory concentration (IC50) at 24,48,72h was 3.8inverted commas1.8inverted commas1.2(mol/L. 7402 cells treated with RG (10(mol/L) presented the characteristics of apoptotic cell and the apoptotic rate was higher than control groups. RG caused a disruption in Δψm and enhanced the release of CytC then activated Caspase-3. RG inhibited expression of Bcl-2 protein. Conclusion: Resibufogenin could induce the apoptosis of Bel-7402 cells in vitro, which is probably achieved through the mitochondrial-dependent pathway.
What problem does this paper attempt to address?